Over the last two years, Republican politicians in the United States have been successful in cutting back or eliminating access to pediatric medical transition. There are now treatment bans in 27 states, representing about half the population. In many states without bans, pressure from the federal Department of Justice has led to the closure of pediatric gender clinics at major hospitals. Clinic closures are now extending beyond major hospitals. When the Los Angeles Children’s Hospital closed its pediatric gender clinic, Joanna Olson-Kennedy, one of the most prominent supporters of medical transition, moved her practice to Prosolio Care. It was just announced that this clinic will also be shutting down. Concerned parents and clinicians have been given some breathing room.
How much of this change will survive the Trump administration is an open question. Transgender activists are holding on to the hope that gender clinics will re-open quickly once Trump leaves office. But Wes Yang has spoken to hospital risk managers who suggest that concerns about reputational and legal risks will keep the clinics shut. It is unlikely that an incoming Democratic president will revert to the same aggressive promotion of gender ideology that marked the Obama and Biden administrations. Executive orders will be repealed, prosecutions and investigations halted and some funding may be restored. However, the issue is now a political liability for the Democrats, so they will want to keep it out of the public eye as much as possible. This means that there will probably be little in the way of legislative action or appointment of trans-identified people to prominent positions in health or education.
Simply stopping the fraud investigations will not be enough to let gender clinics get back in business. One initial question will be whether it is possible to run a profitable pediatric gender clinic without fraudulent billing. Some clinicians have said that the reason they use billing codes other than gender dysphoria is to avoid the “stigma” of a psychiatric diagnosis. However, a series of court decisions on Section 1557 of the Affordable Care Act have limited the obligations of private insurers to provide coverage for gender affirming care. If this is the case, legislative action may be needed to restore funding for gender clinics, and this would expose the weak evidence base for gender medicine to further congressional scrutiny.
However, it should be noted that policy changes in the United States have been partial and limited. Pediatric medical transition is still available in half of the country in doctor’s offices and smaller clinics, although smaller clinics are facing pressure from rising malpractice premiums. Around half of the states still allow pediatric medical transition and these states will be able to fund it
A larger problem is that state treatment bans on medical transition end at age 18. Little has been done to address the problems of social contagion or the lack of holistic mental health support. These are problems that cannot be solved by political or legal action. Solutions will require education and consensus building, which have not been the Trump administration’s strong points.
Stopping the Trans Train
Pediatric gender transition is like a railway journey. The ticket booth is the exposure of vulnerable children to the idea of transgender identity through social media, friends and the education system. The conductors and drivers of the train are the adults who reinforce cross-gender identity through social transition and affirmation only therapy. Medical transition is the destination. Bans on medical transition of minors extend the journey rather than stopping the train.
Until there is change at every level, gender-questioning young people will simply be kept waiting, with growing impatience, until they can access medical transition at eighteen. At that age, their capacity to understand and consent to medical transition is still doubtful. Having to wait a few more years before making irreversible changes to their bodies may give some young people time to change their minds, but that will require mental health support which is now often lacking.
Mental Health Professions
The largest ongoing problem is the current approach of the mental health professions to gender distress. Banning pediatric medical transition and shutting down gender clinics will buy some time for gender questioning young people before they start on a medical pathway, but without good mental health support that time will often be wasted.
Providing good mental health support to gender-questioning young people will require moving beyond the gender affirmative model which is now endorsed by every major mental health organization. The gender affirmative model directs clinicians to affirm a patient’s chosen gender identity and to direct them to medical transition services as desired. Psychological exploration and treatment of co-morbid psychiatric conditions is encouraged but the model denies that there is any connection between gender identity and underlying psychological distress. In actual practice, gender clinics often start patients on hormones after one or two appointments and co-morbid conditions are ignored. There are major obstacles to change.
One is legislation against “conversion therapy” directed at gender identity, which has been interpreted by trans activists to cover any exploratory psychotherapy that probes the causes of gender-related distress. The final report of the Cass Review found that many clinicians in the United Kingdom were concerned about “potential accusations of conversion practice when following an approach that would be considered normal clinical practice when working with other groups of young people.” Conversion therapy laws do contain exemptions that are intended to permit exploratory psychotherapy, but the vagueness of the laws makes effective therapeutic work difficult. Psychiatrist Roberto D’Angelo talks about a “prohibition on knowing” that prevents therapists from exploring the origins of a transgender identity.
The Chiles v. Salazar case in the U.S. Supreme Court called into question the constitutional validity of conversion therapy laws. The Supreme Court decision did not strike down the law but referred the case back to the lower court for review under a strict scrutiny standard. Meanwhile, Colorado has enacted a new ban that it describes as “viewpoint neutral.” Even in states without legislative bans, therapists must often contend with professional association policies and regulations that endorse the gender affirmative model and oppose conversion therapy.
Conversion therapy legislation does contain exemptions for exploratory psychotherapy, but the language is vague. Transgender activists have exploited this vagueness to threaten any therapist who questions the gender affirmative model.
Another major obstacle is the lack of properly trained therapists. Prior to 2015, childhood gender dysphoria was rare and only a few clinics specialized in treating it. Most of these clinics, like the Gender Identity Clinic headed by Ken Zucker, relied on a cautious, watchful waiting approach. Since 2015, the rapid growth in referrals to pediatric gender clinics has been paralleled by an activist campaign to impose an affirmation-only approach as the only acceptable treatment model. Today, therapists can be divided into those who trained at a time when childhood gender dysphoria was very rare and those who were taught the affirmation only approach. The situation has grown worse over time as the influence of transgender activism has spread through faculties of medicine, psychology and biology. Today, even talking about sex as a binary category face protests.
Working for Change
The three organizations that are leading the campaign to reform gender medicine and re-educate therapists are the Society for Evidence Based Gender Medicine (SEGM), Therapy First and Genspect. All three are small and face resistance from transgender activists.
SEGM is concerned mainly with the science supporting gender affirming care. However, it does not endorse specific clinical models or policy recommendations. Most of the materials on SEGM’s website are critiques the methodological flaws of articles supporting medical transition. SEGM also commissioned a series of systematic reviews of aspects of pediatric medical transition from a team at McMaster University. The reviews of puberty blockers, cross-sex hormones and mastectomy have been published. All three found the evidence of any mental health benefits to be of low / very low certainty. The remaining reviews were not published after an activist campaign caused McMaster to withdraw its support.
SEGM has developed a series of continuing medical education webinars based on presentations at its conferences. The program had been accredited as a continuing medical education program, but the accreditation was suspended after complaints. (Medical professionals are required to take a minimum number of hours of continuing medical education from an accredited source each year.) The limitation of SEGM’s work is that it has not yet been able to move from criticizing the evidence base in support of pediatric medical transition to developing an evidence base on alternative approaches.
Meanwhile, Therapy First is working to re-educate therapists on alternatives to the gender affirmative model using the best evidence available. Therapy First is currently approved by the American Psychological Association and the National Board of Clinical Counsellors to provide continuing education programs. Therapy First seems to be walking a fine line to maintain its accredited status. The FAQ section of its website says:
Therapy First promotes and implements the standard of care endorsed by major mental health associations by training and supporting clinicians to provide comprehensive assessments, address co-occurring mental health and developmental concerns, and deliver ongoing therapeutic care that helps young people explore their identity and achieve developmental milestones. This is consistent with the standard of care endorsed by the American Psychological Association, the American Psychiatric Association, and the World Professional Association for Transgender Health, whose guidelines support therapy first for this population.
It qualifies this statement by adding that its references to the WPATH Standard of Care, are “specific only to its recommendations for the mental health care of adolescents experiencing gender dysphoria.”
However, there are significant divergences between Therapy First and the established mental health organizations. For example, the American Psychological Association says that medical transition leads to positive outcomes. Therapy First states,
Multiple systemic reviews conducted in the UK, Sweden, Canada and elsewhere indicate that there is insufficient evidence to recommend hormonal and surgical interventions for gender distressed children and youth.
The Research section of the Therapy First website lists a series of articles that question key assumptions of the gender affirmative model. “Outbreak: On Transgender Teens and Psychic Epidemics” is a 2017 article by Lisa Marchiano which discusses, among other things, the rapid onset gender dysphoria hypothesis and suggests that social contagion may be a factor contributing to the increase in the number of young people seeking treatment for gender dysphoria. A survey of Therapy First members found that many of them encounter hostility when attempting to practice neutral, exploratory therapy with trans-identifying clients.
Therapy First presents its position as implementing the recommendations of WPATH and other major mental health associations on “the importance of therapy that promotes self-discovery and individualized care.” It denies that its approach constitutes conversion therapy but many supporters of the affirming model take a much more restrictive approach of what is acceptable practice. A survey of Therapy First members found that many of them encounter hostility when attempting to practice neutral, exploratory therapy with trans-identifying clients.
Therapy First says that its references to the WPATH Standards of Care “are specific only to its recommendations for the mental health care of adolescents experiencing gender dysphoria.” It says that the WPATH Standards of Care are not a “legal standard of care” but does not directly criticize them.
Genspect takes a much more forceful approach. It acts as an advocacy and support group for parents of gender questioning children and for detransitioners. While it does have a think tank, The Killarney Group, its output is intended for a general audience rather than clinicians and researchers. It offers some strong criticisms of WPATH and the affirming model generally.
Genspect recently launched a “re-psychopathologization” campaign, which it describes as “restoring a psychological approach to gender-related distress.” The goal of the campaign is described in the title of an essay by Mia Hughes, “Trans Is a Mental Disorder: And we must be allowed to say so.” Hughes argues that “the idea that being transgender is a natural variation of human existence, not grounded in mental disorder or psychological challenges” is “nonsensical.” This is the idea that underlies the WPATH Standard of Care and the policy statements of every medical and mental health organization on gender affirming care.
In another essay, Hughes traces the origins of the depsychopathologization of transgender identity. The movement began, not with new research, but with a campaign by a group of transgender activists, most of whom were not scientists or clinicians. This group worked to suppress research on the origins and causes of transgender identity in support of a belief that it was innate and inborn. Research into the origins of transgender identity, which suggested a psychological cause, was attacked. An early target was the work of Ray Blanchard on autogynephilia, which proposed that heterosexual males who identify as transgender are driven by an erotic fixation on the self as female. More recently, the work of Lisa Littman, which hypothesized that the rapid increase of teen girls presenting at gender clinics, was due to social contagion has come under similar attack.
A more formal statement of the campaign’s goals by Hughes and Stella O’Malley says that the goal is to restore “the possibility of recognizing psychological disturbance where it is present and of understanding rigid transgender ideation through the clinical framework of an overvalued belief.”
Re-psychopathologization is an awkward name, and the campaign may be an awkward fit. The concept may be too abstract for a lay audience and some of the language to provocative to appeal to researchers and clinicians. The statement that trans is a mental disorder is as much an unevidenced opinion as the statement that it is a natural variation of human experience. A more scientifically based statement of goals would be something like, “We must be permitted to explore the possibility that some manifestations of transgender identity are grounded in mental disorder.”
However, Genspect raises an important point. It is not possible to provide real evidence-based therapy without an evidence-based understanding of the causes and natural course of the condition that is being treated. Therapists may have to pay lip service to official statements from the American Psychological Association and WPATH to keep their licenses, but they also must contend with the fact that these policies are based on an understanding of gender identity which is grounded in political activism rather than scientific research. To the extent that there are cases of transgender identity rooted in mental disorders, therapists need to be able to acknowledge that fact in order to treat both gender dysphoria and the underlying disorder.
What gender medicine needs is a synthesis of the work of Genspect, SEGM and Therapy First to create an evidence-based diagnosis and evidence-based treatment guidelines for gender related distress which can be used to guide therapists. However, with the issue still so polarized, that is a distant hope.
Therapy First invited Amy Tishelman, Erika Andersen and Laura Edwards-Leeper to speak at their conferences in the fall of 2026. All three have supported and continue to support pediatric medical transition in some circumstances but have, over the last few years, called for greater caution. The conference announcement on X received a number of critical responses, including ones from Erin Friday, of Our Duty, Ms Terfy Teacher and Jonathan Cogburn. Therapist Stephanie Winn wrote a Substack criticizing the choice of speakers. SEGM also invited Andersen and Edwards-Leeper to speak at their 2026 conference. The decision received some criticism on X, but it was more muted.
The anger behind some criticisms is understandable. Most supporters of the affirming care model are not interested in respectful dialogue. Detransitioners, parents and non-affirming therapists have all suffered direct and serious harm at the hands of transgender activists. It is also counterproductive. Change in approach to gender dysphoria can only be achieved by working with the clinicians who are currently treating child and adolescent patients, including those who support medical transition in some cases. The first effective challenge to the affirming model began in Finland when clinicians who had been transitioning youth noticed that their patient population did not match the population in the initial Dutch studies. Dr. Riittakerttu Kaltiala, who has been one of the leading critics of the evidence base for medical transition of minors, has said that she believes that medical gender reassignment may be appropriate in some cases after a thorough psychiatric assessment. The impetus for the Cass Review came from therapists who had been working in the gender identity service at the Tavistock Clinic. There are many more clinicians working with children and adolescents with gender dysphoria who are quietly adopting a more cautious approach.
While it is possible that some of the more extreme ideologues practicing gender medicine will face professional sanctions or huge damage claims, they will be rare. Most of the clinicians who are currently providing pediatric medical transition will continue practicing and will need to be persuaded to change their approach. That means being prepared to talk with them if they are prepared to engage in good faith dialogue.
The current situation in the United States provides the opportunity for a live experiment in non-medical and medical approaches to gender distress in children and adolescents. Treatment bans and clinic closures will give therapists more time to work with young people before they can start to make permanent changes to their bodies. In the short run, many therapists will simply keep their young patients in a holding pattern until they can start medical transition at age 18. However, eventually, they will start to spend more time working with co-morbid mental health issues and slowly begin looking for ways to address their patients’ discomfort with their sexed bodies other than medical transition. It will be interesting to see, in five years time, how patient outcomes in these states compare with states where pediatric medical transition remains available.
The most likely course for pediatric gender medicine, with or without treatment bans, is a slow retreat to the watchful waiting practices that prevailed until around 2015. Without any formal change in policy, assessment periods will become longer, and medical transition will be limited to a very small number of patients aged 16 or 17 who have exhibited severe and prolonged distress.
The recent clinic closures in the U.S. do not mark the end of the debate over pediatric medical transition. What is needed now is to shift the debate from the political arena to the scientific and clinical forums where it should have stayed all along.

I have been thinking a bit more on the roles of SEGM, Therapy First and Genspect. All three play and important role but they all operate under limitations which flow from their focus and mandate. SEGM is a scientific organization and its credibility is based on its commitment to promoting rigorous research. It has to be careful not to outrun the science or get involved in issues of public policy. Therapy First is trying to help patients by educating therapists to work within the existing system. The problem it faces is that there are limits to what can be done to help patients within a system that is broken. Gender ideology still dominates most major mental health organizations and conversion therapy laws and policies are being interpreted in ways that constrain what should be normal mental health practice. Genspect is an advocacy organization which can challenge the dominance of transgender ideology in governments, universities and professional groups. The problem it faces is that the language and approach which is most effective in political campaigning is often not appropriate in scientific and clinical discussion.
I made some changes to the section on Therapy First. It was pointed out to me that I did not sufficiently explain the position set out in the Therapy First FAQ. I apologize for any misunderstanding.